Top Vaccine Conference 2024 | Vaccine Conferences | Virology Meet |Euro Vaccine 2023 Conferences|Vaccines & Immunization 2023| Infectious and non-infectious Conferences

Theme: Expanding Present Vaccine Research Outcomes in the wake of Pandemic

Vaccine Congress-2024

Vaccine Congress-2024

Group Discounts are available

Vaccines Congress 2024 look forward to welcoming all participants around the world to attend the 4^thInternational Conference on Vaccines Research which is scheduled in the month of February 08-09, 2024 to be held at Madrid, Spain. The theme of our conference is "Expanding Present Vaccine Research Outcomes in the wake of Pandemic."

To discover the “future and need” of vaccines, we take this prestigious opportunity to welcome all experts in the field of vaccination around the world.

The event highlights bright and intelligent moments to enable the exchange of ideas in a wide range of controls in the field of Vaccines, research. The workshop includes keynote speeches from learned researchers, plenary sessions, Writing Presentations, Young Researcher sessions, Symposiums, Workshops, and Exhibitions.

This event brings together hundreds of researchers and thought leaders from around the world to look at current trends and innovations in the future of the global vaccination and vaccination arena. Our global platform enables attendees to engage in in-depth research discussions and to consult with international experts.

Target Audience :

The audience who can attend for VACCINE CONGRESS 2024 are Directors, CEOs, Presidents, Vice Presidents, Researchers, Scientists related to Vaccine , Deans, Professors, Associations, Societies related to Vaccine R&D, Vaccine Developers, Vaccine Investigators, Business Entrepreneurs, Vaccine Manufacturing Companies, Vaccination Programme Organizing Government and Non-government Organizations, University Faculty, Medical Schools/Colleges, Nursing Schools/Colleges and Medical Devices Manufacturing Companies.

Track 01: COVID-19 Vaccine

Accurate, evidence-based information about the COVID-19 vaccine to provide people with important facts about vaccines that will help eliminate this problem.

There are more people joining the vaccine at the same time in the COVID-19 pipeline than ever before in an infectious disease. They are all trying to achieve the same thing - the vulnerability of the virus, while others can also stop the transmission of the virus. They do this by stimulating the body's response to the antigen, a molecule found in the virus. In the case of COVID-19, the antigen is usually a spike-derived protein found on the surface of the virus, which is often used to help it attack human cells

Related Global Conferences:

Related Societies:

Europe:

European Society for Immunodeficiency; French Society of Immunology; Immunology of Diabetes Society; Deutsche Gesellschaft fur Immunology

USA:

American Academy of Pediatrics ; American College Health Association ; Association of Immunization Managers ; Association for Professionals in Infection Control and Epidemiology

Asia and Middle-East:

Asia Pacific Association of Allergy, Asthma, and Clinical Immunology ; Asia Pacific Association of Pediatric Allergy, Respirology and Immunology ; Commonwealth of Independent States Society of Allergology and Immunology

Track 02: Vaccines Epidemiology

Vaccines epidemiology – Vaccines - A scientific field that works with testing methods and methods involved in vaccine testing is vaccine epidemiology. The overall purpose of the research field is to provide an understanding of the various methods and techniques involved in evaluating vaccines.

There is a growing increase in vaccines that guarantee life-saving interventions, and the use of epidemiological vaccines maximizes the benefits of this type of primary prevention.

Therefore, it will be considered that manuscripts investigating infection, efficacy of the vaccine, vaccination failure, herd immunity, herd outcome, disease transmission, and modelling of various epidemic diseases

Related Global Conferences:

Related Societies:

Europe:

European Society for Pediatric Infectious Diseases; European Union Geriatric Medicine Society; European Federation of Immunological Societies; European Academy of Allergy and Clinical Immunology; Royal Society of London; Epidemiological Society of London; Edward Jenner Society

USA:

The Anti-Vaccination Society of America ; Infectious Diseases Society of America; Association of Immunization Managers; Clinical Immunology Society

Asia and Middle-East:

Japanese Society for Immunology; Singaporean Society for Immunology; Australasian Society of Clinical Immunology and Allergy

Track 03: Vaccines Immunology

Immunization is a worldwide wellbeing and advancement example of overcoming adversity, saving large number of lives each year. Antibodies diminish dangers of getting a sickness by working with your body's normal safeguards to construct security. At the point when you get an antibody, your resistant framework reacts.

We currently have immunizations to forestall in excess of 20 perilous illnesses, helping individuals of any age live more, better lives. Vaccination as of now forestalls 2-3 million passing consistently from sicknesses like diphtheria, lockjaw, pertussis, flu and measles.

Vaccination is a critical segment of essential medical services and an unquestionable basic liberty. It's additionally extraordinary compared to other wellbeing ventures cash can purchase. Immunizations are additionally basic to the anticipation and control of irresistible illness flare-ups. They support worldwide wellbeing security and will be an imperative apparatus in the fight against antimicrobial opposition

Related Global Conferences:

Related Societies:

Europe:

European Academy of Pediatrics; European Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development ; European malaria Vaccine Initiative

USA:

Autism Science Foundation ; Childhood Influenza Immunization Coalition ;Edward Jenner Vaccine Society; Global Polio Eradication Initiative

Asia and Middle-East:

Lebanese Society of Allergy and Immunology; Moldavian Society of Allergology & Immunology; Moroccan Society of Allergology and Clinical Immunology

Track 04: Vaccine Adjuvants

Adjuvant is an ingredient used in some vaccines that helps to create a strong immune response in people who receive the vaccine. In other words, supplements help make vaccines work better. Some vaccines made from weakened or killed bacteria contain natural supplements and help the body produce a strong immune response. However, many vaccines developed today include only small amounts of viruses, such as their proteins, rather than the whole virus or bacteri

Related Global Conferences:

Related Societies:

Europe:

European Society for Immunodeficiency; French Society of Immunology; Immunology of Diabetes Society; Deutsche Gesellschaft fur Immunology

USA:

American Academy of Pediatrics ; American College Health Association ; Association of Immunization Managers ; Association for Professionals in Infection Control and Epidemiology

Asia and Middle-East:

Asia Pacific Association of Allergy, Asthma and Clinical Immunology ; Asia Pacific Association of Pediatric Allergy, Respirology and Immunology ; Commonwealth of Independent States Society of Allergology and Immunology

Track 05: Vaccine Regulatory Issues

Vaccine Regulatory Issues regulatory issues dealing with vaccination control, production, distribution and control can be termed as vaccine control problems. Common issues and disputes arising from the research and experimental field that include vaccines can also be put together and dealt with under vaccine control problems.

Related Global Conferences:

Related Societies:

Europe:

Croatian Society of Allergology and Clinical Immunology; Czech Society of Allergology and Clinical Immunology; Finnish Society of Allergology and Clinical Immunology; French Society of Allergology and Clinical Immunology

USA:

Panamanian Association of Allergology and Clinical Immunology; Paraguayan Society of Allergy, Asthma, and Immunology; Peruvian Society of Allergy and Immunology; Venezuelan Society of Allergy, Asthma and Immunology

Asia and Middle-East:

Philippine Society of Allergy, Asthma and Immunology; Taiwan Academy of Pediatric Allergy Asthma Immunology; Vietnam Association of Allergy, Asthma and Clinical Immunology

Track 06: Vaccine Research & Development

Research and development of vaccines are becoming increasingly difficult with the emergence of new diseases, an increase in the burden of infectious diseases, and growing concerns about the safety of vaccines. Vaccines are very effective in preventing illness and death, and are widely regarded as one of the great achievements in medicine, but the quantity and quality of the viral response can greatly affect the effectiveness of the vaccine. The complexity of the immune system is an area we understand, and our immunization research services can translate your system into a clinic.

Related Global Conferences:

Related Societies:

Europe:

USA:

Panamanian Association of Allergology and Clinical Immunology; Paraguayan Society of Allergy, ; Peruvian Society of Allergy and Immunology; Venezuelan Society of Allergy, Asthma and Immunology

Asia and Middle-East:

Philippine Society of Allergy, Asthma and Immunology; Taiwan Academy of Pediatric Allergy Asthma Immunology; Vietnam Association of Allergy, Asthma and Clinical Immunology

Track 07: Cancer Vaccines

Antiretroviral drugs n are prescribed for healthy people to help prevent infections, such as measles and leprosy. These vaccines use weakened or killed germs such as germs or bacteria to trigger an immune response. Many cancer vaccines work in the same way, but they cause the human immune system to invade cancer cells. Cancer treatments are different from antiretroviral drugs. These vaccines try to make the immune system attack the cancer cells in the body. Some cancer vaccines are made up of cancer cells and parts of cells, or pure antigens. Sometimes a patient's body cells are separated and exposed to these laboratory substances to create a vaccine. Once the vaccine is ready, it is injected into the body to increase the body's resistance to cancer cells. Cancer drugs cause the immune system to attack cells with one or more antigens. The immune system contains special memory cells, it is hoped that the vaccine may continue to function for a long time after being given.

Related Global Conferences:

Related Societies:

Europe:

European Society for Immunodeficiency; French Society of Immunology; Immunology of Diabetes Society; Deutsche Gesellschaft fur Immunologie

USA:

American Academy of Pediatrics ; American College Health Association ; Association of Immunization Managers ; Association for Professionals in Infection Control and Epidemiology

Asia and Middle-East:

Track 08: Chicken pox Vaccines

The vaccine contains a live version of the weakened varicella-zoster virus (chicken pox). This stimulates the immune system but does not cause infections in healthy people. However, the chicken pox vaccine should not be given to people who have an immune system

Chickenpox is a disease that causes inflammation and fever. A person with chickenpox can have many blisters - up to 500. The rash can spread to the rest of the body - even to the mouth, hips, or genitals. Chickenpox can be dangerous and life-threatening, especially in children, adults, and people with weakened immune systems

Related Global Conferences:

Related Societies:

Europe:

British Society for Immunology; Microbiology Society , London; Royal Society of London; Epidemiological Society of London ; Edward Jenner Society; Society for Applied Microbiology ; European Society of Clinical Microbiology and Infectious Diseases

USA:

The Federation of Clinical Immunology Societies; The American Association of Immunologists; American Society for Microbiology; Colombian Allergy, Asthma and Immunology Association; Canadian Society for Immunology

Asia and Middle-East:

Indian society of Allergy, Asthma and Clinical Immunology; Australasian Society of Clinical Immunology and Allergy; Bangladesh Society of Allergy and Immunology

Track 09: Component Vaccines

Vaccines contain an active substance antigen that stimulates the body's response. They may also contain other substances such as preservatives, additives, adjuvants and other trace elements. This paper provides information on the components of a vaccine including why they are available, and what, if any, could be harmful to these potential components for those receiving the vaccine. General information on the components of the vaccine

Related Global Conferences:

Related Societies:

Europe:

Swiss Society for Microbiology; Societies; International; International Union of Immunological Society; Royal Society of London; Epidemiological Society of London; Edward Jenner Society

USA:

Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy,Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clinical Immunology

Asia and Middle-East:

Indonesian Society of Allergy and Immunology; Korean Academy of Asthma, Allergy and Clinical Immunology; Malaysian Society of Allergy and Immunology

Track 10: Ebola vaccines

The Ebola vaccine will be available in all countries to respond to the outbreak as part of the Gavi-sponsored emergency fund around the world. This will mean that for the first time licensed doses of up to 500,000 Ebola vaccines will be ready for use at the onset of the outbreak, where low and moderate and eligible Gavi countries can receive free doses, with support for operating costs to deal with outbreaks. For the first time in history, the next time Ebola strikes we are ready The vaccine, developed by Merck Sharpe & Dome (or Merck as it is known in the United States and Canada), has already helped end the recent Ebola outbreak in the northern Democratic Republic of the Congo , the fourth of four years in the country.

Related Global Conferences:

Related Societies:

Europe:

European Academy of Pediatrics; European Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development ; European malaria Vaccine Initiative

USA:

Autism Science Foundation ; Childhood Influenza Immunization Coalition ; Edward Jenner Vaccine Society; Global Polio Eradication Initiative

Asia and Middle-East:

Lebanese Society of Allergy and Immunology; Moldavian Society of Allergology & Immunology; Moroccan Society of Allergology and Clinical Immunology

Track 11: HIV Vaccines

Historically, immunizations have been the best way to protect people from infectious diseases. Although there are a variety of strategies available to prevent HIV infection, developing a safe and effective HIV vaccine remains the key to seeing a lasting end to the HIV epidemic. NIAID-backed scientists are working on a two-pronged approach to HIV vaccine: an artistic approach that quickly stimulates human immunodeficiency testing in humans, and a theoretical approach to vaccine-based vaccines based on an understanding of the body's response to HIV infection

Related Global Conferences:

Related Societies:

Europe:

European Academy of Allergy and Clinical Immunology ; European Molecular Biology Laboratory ; Medical Research Council ; Royal Society of London; Epidemiological Society of London; Edward Jenner Society

USA:

Hepatitis B Foundation ; Infectious Diseases Society of America ; National Adult and Influenza Immunization Summit ; National Foundation for Infectious Diseases ; Pediatrics Infectious Diseases Society

Asia and Middle-East:

Russian Association of Allergology and Clinical Immunology; Turkish National Society of Allergy and Clinical Immunology; Ukrainian Association of Allergologists and Clinical Immunologists

Track 12: Human Papilloma Virus Vaccine

HPV vaccines protect against infection with human papillomaviruses (HPV). HPV is a group of more than 200 related viruses, of which more than 40 are spread through direct sexual contact. Among these, two HPV types cause genital warts, and about a dozen HPV types can cause certain types of cancer—cervical, anal, oropharyngeal, penile, vulvar, and vaginal

Related Global Conferences:

Related Societies:

Europe:

USA:

Asia and Middle-East:

Russian Association of Allergology and Clinical Immunology; Turkish National Society of Allergy and Clinical Immunology; Ukrainian Association of Allergologists and Clinical Immunologists

Track 13: MMR Vaccines

Measles causes fever, rash, cough, runny nose, and red, watery eyes. Complications can include ear infections, diarrhea, pneumonia, brain damage and death.

mumps root fever, headaches, muscle aches, fatigue, loss of appetite, and swollen salivary glands. Complications can include swollen testicles or eggs, deafness, inflammation of the brain and / or tissues including the brain and spine (encephalitis / meningitis) and, rarely, die.

Rubella root fever, sore throat, rash, headache, and red, itchy eyes. If a woman gets rubella during pregnancy, she may become pregnant or her baby may be born with a serious birth defect.

You can protect yourself from these diseases with a safe, effective vaccine.

Related Global Conferences:

Related Societies:

Europe:

European Society for Pediatric Infectious Diseases; European Union Geriatric Medicine Society; European Federation of Immunological Societies; European Academy of Allergy and Clinical Immunology

USA:

The Anti-Vaccination Society of America ; Royal Society of London; Epidemiological Society of London; Edward Jenner Society ; Infectious Diseases Society of America; Association of Immunization Managers; Clinical Immunology Society

Asia and Middle-East:

Japanese Society for Immunology; Singaporean Society for Immunology; Australasian Society of Clinical Immunology and Allergy

Track 14: Polio Vaccines

Polio is a crippling and potentially fatal disease. It is caused by poliovirus. The virus spreads from person to person and can infect the brain and spinal cord of an infected person, causing paralysis (unable to move body parts. Polio can be prevented by vaccination. Inactive Polio Vaccine (IPV) is the only polio vaccine supplied in the United States since 2000. You are given a shot in the arm or leg, depending on the age of the person. Oral polio vaccine (OPV) is used in some countries.

Almost all children (99 out of 100) who receive all the recommended doses of polio vaccine will be protected from polio

Related Global Conferences:

Related Societies:

Europe:

British Society for Allergy and Clinical Immunology; British Society for Histocompatibility and Immunogenetics; European Federation of Immunological Societies; European Academy of Allergology and Clinical Immunology

USA:

Voices for Vaccines ; National Institute of Allergy and Infectious Disease ; American Public Health Association ; American Association for the Advancement of Science ; American Society for Microbiology .

Asia and Middle-East:

Australasian Society for Immunology; Australasian Society of Clinical Immunology and Allergy; Israel Association of Allergy and Clinical Immunology; Jordanian Society for Allergy and Clinical Immunology; Japanese Society for Immunology

Track 15: Preclinical Vaccine Studies

Pre-Clinical Vaccine Studies - These studies are conducted before clinical trials and can be called " Preclinical vaccines Studies" These studies are conducted to assess the safety, immunogenicity and therapeutic efficacy of the vaccine and to seek vaccine treatment for a variety of animals. These are non-clinical studies conducted by vaccine manufacturers before clinical trials

Related Global Conferences:

Related Societies:

Europe:

Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; Royal Society of London; Epidemiological Society of London; Edward Jenner Society; International Union of Immunological Society

USA:

Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clincial Immunology

Asia and Middle-East:

Indonesian Society of Allergy and Immunology ; Korean Academy of Asthma , Allergy and Clinical Immunology; Malaysian Society of Allergy and Immunology

Track 16: Recombinant Vector Vaccines

Recombinant vector vaccines are recurring drugs designed to carry additional genes taken from the pathogen - and these extra genes produce the proteins we want to be able to protect ourselves with. These vaccine molecules can change and lose additional genes during the vaccine process or during recurrence within a person, and there is concern that this evolution could severely limit the effectiveness of the vaccine. The effectiveness of this process is learned here by mathematical models. The evolutionary potential of the vaccine within the institution is reduced by the temporary increase in the number of vaccines before the immune response is suppressed.

Related Global Conferences:

Related Societies:

Europe:

European Society for Pediatric Infectious Diseases; European Union Geriatric Medicine Society; European Federation of Immunological Societies ; European Academy of Allergy and Clinical Immunology

USA:

The Anti-Vaccination Society of America; Royal Society of London ; Epidemiological Society of London; Edward Jenner Society; Infectious Diseases Society of America; Association of Immunization Managers; Clinical Immunology Society

Asia and Middle-East:

Japanese Society for Immunology; Singaporean Society for Immunology; Australasian Society of Clinical Immunology and Allergy

Track 17: Vaccines Dermatology

Vaccine hesitancy is a growing threat to the health of individuals and communities that needs to be addressed by all physicians. In our experience, dermatologists have always been faithful in promoting vaccines, perhaps because of information limitations or time constraints; however, this situation must change. Dermatologists should play a leading role in promoting vaccines, which is a proven and effective method of promoting public health.

Related Global Conferences:

Related Societies:

Europe:

Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; International Union of Immunological Society; Royal Society of London; Epidemiological Society of London; Edward Jenner Society

USA:

Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clin Related Societies

Europe:

Swiss Society for Microbiology ; Federation of European Microbiological Societies; International Society of Vaccines; International Union of Immunological Society; Royal Society of London; Epidemiological Society of London; Edward Jenner Society

Track 18: Veterinary Vaccines

Veterinary vaccines have been instrumental in protecting animal and public health, reducing animal suffering, enabling effective animal production to feed a growing population, and significantly reducing the need for antimicrobials to manage and interact with animals. Prominent examples include antiretroviral drugs and rinderpest vaccines. Rabies vaccination against pets and wildlife has almost eliminated human rabies in developed countries.

Related Global Conferences:

Related Societies:

Europe:

USA:

Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clin Related Societies

Europe:

Swiss Society for Microbiology ; Federation of European Microbiological Societies; International Society of Vaccines; International Union of Immunological Society; Royal Society of London; Epidemiological Society of London; Edward Jenner Society

Track 19: Childhood Vaccines

It is always better to prevent the disease than to treat it after it has already developed. The most common national and international diseases, including polio, measles, diphtheria, pertussis (cough), rubella (German measles), smallpox, measles, rotavirus and Haemophilus influenzae type b (Hib) are now can be prevented by vaccination. Thanks to the vaccine, one of the worst diseases in history - smallpox - is no longer outside the laboratory. Over the years vaccines have protected countless diseases and saved millions of lives

Related Global Conferences:

Related Societies:

Europe:

USA:

Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clincial Immunology

Asia and Middle-East:

Indonesian Society of Allergy and Immunology ; Korean Academy of Asthma , Allergy and Clinical Immunology; Malaysian Society of Allergy and Immunology

Track 20: Tuberculosis Vaccines

Tuberculosis (TB) is a vaccine aimed at preventing TB. Anti-TB immunotherapy was first proposed in 1890 by Robert Koch. Today, the only effective anti-tuberculosis drug used is bacilli Calmette-Guérin, first used in humans in 1921. About 3 out of every 10,000 people who receive the vaccine have side effects, often less so than people with severe depression. While the BCG vaccine provides effective protection for infants and young children, (including protection against TB meningitis and miliary TB), its effectiveness in adults varies, from 0% to 80%. The need for improved immunity to TB exists because the disease is already drug-resistant

Related Global Conferences:

Related Societies:

Europe:

USA:

Asia and Middle-East:

Russian Association of Allergology and Clinical Immunology; Turkish National Society of Allergy and Clinical Immunology; Ukrainian Association of Allergologists and Clinical Immunologists

VACCINE CONGRESS 2024 are aimed at opening the door to research by researchers from around the world on immunization, Immunology, and its development; this is a great opportunity to get to a large gathering of members from Vaccines Immunology and a network of clinical testing. It provides a section that introduces introductions, relevant data, meets existing and potential researchers, makes a splash with new antibody enhancements, and acquires brand name for the event. The most respected speakers, the latest methods, improvements, and the latest updates on Vaccines Immunology, and clinical trials are the hallmarks of this circle

• Sharpen your knowledge.

• Gain and share new ideas and best practices.

• Learn about the latest innovations and insights.

• Meet influencers and industry experts face to face.

• Make new contacts and stay connected with friends and colleagues.

• Team building.

VACCINE CONGRESS 2024 Vaccines Market size exceeded USD 42 billion by 2021 and expects to grow by more than 15.7% (USD 49 billion ) CAGR between 2022 and 2026. Vaccination programs and programs developed by government officials to improve health outcomes will increase market demand. Recent cases of coronavirus infection have affected millions of people worldwide. The relocation of the community to other regions has led to an increase in victims worldwide. Currently, biopharmaceutical and biotechnological companies are focusing on expanding research and developing COVID-19 drugs. The Covid flare-up has given a different interest and firms have put more resources into testing and support by community authorities.

Market Analysis for Vaccines Conference aims to bring together major academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Market Analysis for Vaccines Conference. It also provides a main interdisciplinary platform for researchers, practitioners, and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and resolution adopted in the fields of Market Analysis for Vaccines Conference.

The extension of the merger offices that commit high interest rates will strengthen the business development potential. Pollution is one of the greatest threats to the human lion's share in building as a developed country. Due to the emergence of undiagnosed diseases, for example, hepatitis and human papilloma infection, the antibody market will expect significant growth. In any case, strong management strategies will affect the development cycle. Also, high prices and the cost of vaccines can disrupt market volatility to some extent. Vaccination speaks of perhaps the greatest achievements in science and medicine in the fight against preventable diseases. Inoculation is one of the most economically viable tools for preventing preventable diseases. Significant progress has been made in increasing global policy, bringing the expectation of more than 2,000,000 annual passes. The development of this market is due to the high prevalence of infection, the increase in government activities in vaccination, the increase in vaccine adoption, the continuation of equipment in the antibody industry, and the strong antibody pipeline

Fig: Vaccine Research

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	February 08-09, 2024
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View